Rigel to Present at the Piper Sandler 37th Annual Healthcare Conference
Rigel (Nasdaq: RIGL) will present a company overview at the Piper Sandler 37th Annual Healthcare Conference on Wednesday, December 3, 2025 at 8:30 am ET.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Rigel (Nasdaq: RIGL) will present a company overview at the Piper Sandler 37th Annual Healthcare Conference on Wednesday, December 3, 2025 at 8:30 am ET. Dean Schorno, chief financial officer, will deliver the presentation.
Investors can access a live webcast and archived recording via the Investor Relations section of Rigel's website at www.rigel.com; attendees are advised to connect to the site before the start time to allow for any software downloads.
Details
News Market Reaction – RIGL
On Nov 26, the day this news came out, RIGL closed 2.82% above the previous close.
Data tracked by StockTitan Argus for the Nov 26 session.
Key Figures
- Conference presentation time
- December 3, 2025, 8:30 am ET
- Piper Sandler 37th Annual Healthcare Conference company overview
Historical Context
-
Announcement of Piper Sandler healthcare conference presentation webcast access.
-
Publication of final five‑year REZLIDHIA Phase 2 data in AML.
-
Jefferies Global Healthcare Conference presentation with webcast access.
-
Strong Q3 2025 financials and raised 2025 revenue guidance.
-
Announcement of one oral and four poster presentations at ASH.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
hematologic disorders medical
AI-generated analysis. How Rhea-AI works. Not financial advice.
To access the live webcast or archived recording, visit the Investor Relations section of the company's website at www.rigel.com. Please connect to Rigel's website prior to the start of the live webcast to allow for any software downloads.
About Rigel
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) is a biotechnology company dedicated to discovering, developing and providing novel therapies that significantly improve the lives of patients with hematologic disorders and cancer. Founded in 1996, Rigel is based in
Contact for Investors & Media:
Investors:
Rigel Pharmaceuticals, Inc.
650.624.1232
ir@rigel.com
Media:
David Rosen
Argot Partners
646.461.6387
david.rosen@argotpartners.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/rigel-to-present-at-the-piper-sandler-37th-annual-healthcare-conference-302626268.html
SOURCE Rigel Pharmaceuticals, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.